Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients von van Vollenhoven, Ronald F, Emery, Paul, Bingham, Clifton O, Keystone, Edward C, Fleischmann, Roy M, Furst, Daniel E, Tyson, Nicola, Collinson, Neil, Lehane, Patricia B

Volltext

Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naive patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from... von Emery, P, Bingham, COIII, Burmester, GR, Bykerk, VP, Furst, DE, Mariette, X, van, der Heijde D, van, Vollenhoven R, Arendt, C, Mountian, I

Volltext

Efficacy and safety of certolizumab pegol in a broad population of patients with active rheumatoid arthritis: results from the REALISTIC phase IIIb study von WEINBLATT, Michael E, FLEISCHMANN, Roy, GOEL, Niti, DAVIES, Owen R, DOUGADOS, Maxime, HUIZINGA, Tom W. J, EMERY, Paul, POPE, Janet, MASSAROTTI, Elena M, VOLLENHOVEN, Ronald F. Van, WOLLENHAUPT, Jürgen, BINGHAM, Clifton O, DUNCAN, Ben

Volltext

Advancing the Development of Patient-reported Outcomes for Adult Myositis at OMERACT 2016: An International Delphi Study von Park, JK, Mecoli, CA, Alexanderson, H, Regardt, M, Christopher-Stine, L, Casal-Dominguez, M, de, Groot I, Sarver, C, Lundberg, IE, Bingham, COIII

Volltext

Efficacy and safety of tabalumab, an anti-B-cell-activating factor monoclonal antibody, in patients with rheumatoid arthritis who had an inadequate response to methotrexate therapy... von Smolen, Josef S, Weinblatt, Michael E, van der Heijde, Désirée, Rigby, William F C, van Vollenhoven, Ronald, Bingham, Clifton O, Veenhuizen, Melissa, Gill, Anne, Zhao, Fangyi, Komocsar, Wendy J, Berclaz, Pierre-Yves, Ortmann, Robert, Lee, Chin

Volltext

Patient-reported Outcomes and Adult Patients' Disease Experience in the Idiopathic Inflammatory Myopathies. Report from the OMERACT 11 Myositis Special Interest Group von Alexanderson, H, Del, Grande M, Bingham, COIII, Orbai, A-M, Sarver, C, Clegg-Smith, K, Lundberg, IE, Song, YW, Christopher-Stine, L

Volltext

Advancing the Development of Patient-reported Outcomes for Adult Myositis at OMERACT 2016: An International Delphi Study (vol 44, pg 1683, 2017) von Park, JK, Mecoli, CA, Alexanderson, H, Regardt, M, Christopher-Stine, L, Casal-Dominguez, M, de, Groot I, Sarver, C, Lundberg, IE, Bingham, COIII

Volltext

A 2 yr longitudinal radiographic study examining the effect of a bisphosphonate (risedronate) upon subchondral bone loss in osteoarthritic knee patients von Buckland-Wright, J. C., Messent, E. A., Bingham, C. O., Ward, R. J., Tonkin, C.

Volltext

Advancing the Development of Patient-reported Outcomes for Adult Myositis at OMERACT 2016: An International Delphi Study (vol 44, pg 1683, 2017) von Park, JK, Mecoli, CA, Alexanderson, H, Regardt, M, Christopher-Stine, L, Casal-Dominguez, M, de, Groot I, Sarver, C, Lundberg, IE, Bingham, COIII

Volltext

Response to: 'Let's stop fooling ourselves. In RA, only ACR/EULAR criteria define remission and equate with absence of disease!' by Boers von Emery, P, Bingham, 3rd, C O, Burmester, G R, Bykerk, V P, Furst, D E, Mariette, X, Heijde, D van der, Vollenhoven, R van, Arendt, C, Mountian, I, Purcaru, O, Tatla, D, VanLunen, B, Weinblatt, M E

Volltext

Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies... von Bingham, C. O., Sebba, A. I., Rubin, B. R., Ruoff, G. E., Kremer, J., Bird, S., Smugar, S. S., Fitzgerald, B. J., O'Brien, K., Tershakovec, A. M.

Volltext